Print

Print


thx to all who wrote to help me open the newsletter..here's the part on dopamine hci.  Joan
----- Original Message -----
From: [log in to unmask]>Joan Hartman
To: [log in to unmask]>[log in to unmask]
Sent: Monday, August 09, 1999 7:04 PM
Subject: medwatch dopamine (again)

sorry I forgot to enclosed the email...Joan
FYI -
The following products had safety-realted labeling changes approved by FDA
in June 1999.  You can find the summaries at
http:/www.fda.gov/medwatch/safety/1999/jun99.htm

MedWatch

AGGRASTAT (tirofiban HCl)
CARDIOQUIN (quinidine polygalacturonate)
CRIXIVAN (indinavir sulfate)
CUTIVATE (fluticasone propionate)
DIOVAN HCT (valsartan/hydrochlorothiazide)
DIPENTUM (olsalazine Na)
DOPAMINE HCl
DOXIL (doxorubicin HCl liposome)
ETHYOL (amifostine)
FOSAMAX (alendronateNa)
HELIDAC (bismuth subsalicylate/metronidazole/tetracycline HCl)
ISMO (isosorbide mononitrate)
ISORDIL (isosorbide dinitrate)
LOTREL (amlodipine besylate/benazepril)
NORPLANT (levonorgestrel implants)
NORVIR (ritonavir)
PHENDIMETRAZINE TARTRATE
PREMARIN (conjugated estrogens)
PREVEN (levonorgestrel/ethinyl estradiol)
PROVENTIL-HFA (albuterol sulfate)
PROZAC (fluoxetine)
QUINIDINE GLUCONATE
REZULIN (troglitazone)
VERELAN (verapamil HCl)
VIAGRA (sildenafil citrate)